These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15958389)

  • 1. Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification.
    Hofmann TG; Jaffray E; Stollberg N; Hay RT; Will H
    J Biol Chem; 2005 Aug; 280(32):29224-32. PubMed ID: 15958389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability.
    Gresko E; Möller A; Roscic A; Schmitz ML
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1293-9. PubMed ID: 15766567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
    Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
    Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of nuclear HIPK2 localization and function by a SUMO interaction motif.
    de la Vega L; Fröbius K; Moreno R; Calzado MA; Geng H; Schmitz ML
    Biochim Biophys Acta; 2011 Feb; 1813(2):283-97. PubMed ID: 21145359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1.
    Kim YH; Choi CY; Kim Y
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12350-5. PubMed ID: 10535925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.
    Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD
    Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells.
    Hofmann TG; Stollberg N; Schmitz ML; Will H
    Cancer Res; 2003 Dec; 63(23):8271-7. PubMed ID: 14678985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
    Harada J; Kokura K; Kanei-Ishii C; Nomura T; Khan MM; Kim Y; Ishii S
    J Biol Chem; 2003 Oct; 278(40):38998-9005. PubMed ID: 12874272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1.
    Kim YH; Sung KS; Lee SJ; Kim YO; Choi CY; Kim Y
    FEBS Lett; 2005 Nov; 579(27):6272-8. PubMed ID: 16253240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
    Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
    J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains.
    Möller A; Sirma H; Hofmann TG; Rueffer S; Klimczak E; Dröge W; Will H; Schmitz ML
    Cancer Res; 2003 Aug; 63(15):4310-4. PubMed ID: 12907596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
    Kim EJ; Park JS; Um SJ
    J Biol Chem; 2002 Aug; 277(35):32020-8. PubMed ID: 11925430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation.
    Sung KS; Go YY; Ahn JH; Kim YH; Kim Y; Choi CY
    FEBS Lett; 2005 Jun; 579(14):3001-8. PubMed ID: 15896780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.
    Agnew C; Liu L; Liu S; Xu W; You L; Yeung W; Kannan N; Jablons D; Jura N
    J Biol Chem; 2019 Sep; 294(37):13545-13559. PubMed ID: 31341017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.
    Isono K; Nemoto K; Li Y; Takada Y; Suzuki R; Katsuki M; Nakagawara A; Koseki H
    Mol Cell Biol; 2006 Apr; 26(7):2758-71. PubMed ID: 16537918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage.
    Gresko E; Ritterhoff S; Sevilla-Perez J; Roscic A; Fröbius K; Kotevic I; Vichalkovski A; Hess D; Hemmings BA; Schmitz ML
    Oncogene; 2009 Feb; 28(5):698-708. PubMed ID: 19015637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.
    Hofmann TG; Möller A; Sirma H; Zentgraf H; Taya Y; Dröge W; Will H; Schmitz ML
    Nat Cell Biol; 2002 Jan; 4(1):1-10. PubMed ID: 11740489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
    Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
    Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1.
    Choi DW; Seo YM; Kim EA; Sung KS; Ahn JW; Park SJ; Lee SR; Choi CY
    J Biol Chem; 2008 Feb; 283(8):4682-9. PubMed ID: 18093972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.